Hervolution Therapeutics

Dark Genome-Derived Therapeutics Targeting Cellular Senescence in Cancer & Metabolic Disease

Hervolution Therapeutics is a biotech company in Frederiksberg, Denmark, founded in 2019. It has raised $18.2M across 2 rounds, most recently an $11.7M Series A in December 2024.

Headquarters
Frederiksberg
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$18.2M
Last Round
$11.7M Series ADec 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. to use credits for reveals, or explore the API.

About

HERVolution Therapeutics (formerly InProTher Aps) is a dark genome-focused biotechnology company headquartered in Frederiksberg, Denmark, pioneering novel immunotherapies that target Human Endogenous Retroviruses (HERVs) — specifically HERV-K — as therapeutic antigens in cancer, metabolic disease, and aging-related conditions. Founded in 2019 by University of Copenhagen researcher Peter Holst, the company is based on the discovery that HERVs, genetic remnants of ancient retroviruses integrated into the human genome, become aberrantly reactivated in chronic inflammation, metabolic stress, and cancer, driving immune evasion, cellular senescence, and disease progression. HERVolution has rationally redesigned HERV-K antigens to break immune tolerance, demonstrating human immune cell activation toward HERVs for the first time, and is developing off-the-shelf immunotherapy assets targeting HERV-K across oncology and type 2 diabetes. The company raised an $11.7 million Series A in December 2024 and a further $6.5 million to bring total funding to approximately $18.2 million.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2024
$11.7M

1 more funding event

  • Seed2 investors

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×1
  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hervolution Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/hervolution-therapeutics"><img src="https://indexed.vc/api/badge/company/hervolution-therapeutics" alt="Hervolution Therapeutics on Indexed.vc" width="260" height="76" /></a>